Drug regulator Drugs Controller General of India (DCGI) has approved Itolizumab, for restricted emergency use on Covid-19 patients with moderate to severe acute respiratory distress. Itolizumab is already in use to cure skin ailment psoriasis. Drug maker Biocon has been selling the medicine under brand Alzumab in India for psoriasis since 2013.from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/3iSGhQl
Latest New Breaking News Today, National, World, Indian News Fast, English News Breaking, Latest English News, Breaking News, Read the Latest News On Business, Politics, Sports, Cream, Top Story, Cricket, Sports, Entertainment & Much More From India And Around The World, breaking news,city news,India news,international news,latest news,national news,world news,latest national news,breaking world news,trending news,current news,latest news India
No comments:
Post a Comment